{
    "organizations": [],
    "uuid": "dc14dfe2045c338c6d5c7bb175338ea256429fa3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-prometic-receives-rare-pediatric-d/brief-prometic-receives-rare-pediatric-disease-designation-from-u-s-fda-for-its-inter-alpha-inhibitor-proteins-idUSFWN1QN0GO",
    "ord_in_thread": 0,
    "title": "BRIEF-Prometic Receives Rare Pediatric Disease Designation From U.S. FDA For Its Inter-Alpha-Inhibitor-Proteins",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 5 (Reuters) - Prometic Life Sciences Inc:\n* PROMETIC RECEIVES RARE PEDIATRIC DISEASE DESIGNATION FROM U.S. FDA FOR ITS INTER-ALPHA-INHIBITOR-PROTEINS\n* PROMETIC LIFE SCIENCES INC - ‍COSTS ASSOCIATED WITH CLINICAL PROGRAM WILL NOT IMPACT FY2018​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-05T20:16:00.000+02:00",
    "crawled": "2018-03-06T22:09:42.028+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "prometic",
        "life",
        "science",
        "inc",
        "prometic",
        "receives",
        "rare",
        "pediatric",
        "disease",
        "designation",
        "fda",
        "prometic",
        "life",
        "science",
        "inc",
        "associated",
        "clinical",
        "program",
        "impact",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}